BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38070485)

  • 1. Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies.
    van Die MD; Bone KM; Visvanathan K; Kyrø C; Aune D; Ee C; Paller CJ
    JNCI Cancer Spectr; 2024 Jan; 8(1):. PubMed ID: 38070485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soy, Soy Isoflavones, and Protein Intake in Relation to Mortality from All Causes, Cancers, and Cardiovascular Diseases: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.
    Nachvak SM; Moradi S; Anjom-Shoae J; Rahmani J; Nasiri M; Maleki V; Sadeghi O
    J Acad Nutr Diet; 2019 Sep; 119(9):1483-1500.e17. PubMed ID: 31278047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lignans intake and enterolactone concentration and prognosis of breast cancer: a systematic review and meta-analysis.
    Liu Z; Fei YJ; Cao XH; Xu D; Tang WJ; Yang K; Xu WX; Tang JH
    J Cancer; 2021; 12(9):2787-2796. PubMed ID: 33854638
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry.
    Zhang FF; Haslam DE; Terry MB; Knight JA; Andrulis IL; Daly MB; Buys SS; John EM
    Cancer; 2017 Jun; 123(11):2070-2079. PubMed ID: 28263368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of food groups and dietary pattern with breast cancer risk: A systematic review and meta-analysis.
    Shin S; Fu J; Shin WK; Huang D; Min S; Kang D
    Clin Nutr; 2023 Mar; 42(3):282-297. PubMed ID: 36731160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies.
    Lahart IM; Metsios GS; Nevill AM; Carmichael AR
    Acta Oncol; 2015 May; 54(5):635-54. PubMed ID: 25752971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.
    Qiu S; Jiang C
    Eur J Nutr; 2019 Dec; 58(8):3079-3090. PubMed ID: 30382332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project.
    Nechuta S; Caan BJ; Chen WY; Kwan ML; Lu W; Cai H; Poole EM; Flatt SW; Zheng W; Pierce JP; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1451-6. PubMed ID: 23765086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.
    Guha N; Kwan ML; Quesenberry CP; Weltzien EK; Castillo AL; Caan BJ
    Breast Cancer Res Treat; 2009 Nov; 118(2):395-405. PubMed ID: 19221874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women.
    Nechuta SJ; Caan BJ; Chen WY; Lu W; Chen Z; Kwan ML; Flatt SW; Zheng Y; Zheng W; Pierce JP; Shu XO
    Am J Clin Nutr; 2012 Jul; 96(1):123-32. PubMed ID: 22648714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.
    Touillaud MS; Thiébaut AC; Fournier A; Niravong M; Boutron-Ruault MC; Clavel-Chapelon F
    J Natl Cancer Inst; 2007 Mar; 99(6):475-86. PubMed ID: 17374837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-diagnosis and early post-diagnosis dietary soy isoflavone intake and survival outcomes: A prospective cohort study of early stage breast cancer survivors.
    Ho SC; Yeo W; Goggins W; Kwok C; Cheng A; Chong M; Lee R; Cheung KL
    Cancer Treat Res Commun; 2021; 27():100350. PubMed ID: 33770661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer.
    Olsen A; Christensen J; Knudsen KE; Johnsen NF; Overvad K; Tjønneland A
    Breast Cancer Res Treat; 2011 Aug; 128(3):883-9. PubMed ID: 21340481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea (Camellia sinensis) for the prevention of cancer.
    Filippini T; Malavolti M; Borrelli F; Izzo AA; Fairweather-Tait SJ; Horneber M; Vinceti M
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD005004. PubMed ID: 32118296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
    Seibold P; Vrieling A; Johnson TS; Buck K; Behrens S; Kaaks R; Linseisen J; Obi N; Heinz J; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Aug; 135(4):923-33. PubMed ID: 24436155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates and other bone agents for breast cancer.
    O'Carrigan B; Wong MH; Willson ML; Stockler MR; Pavlakis N; Goodwin A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003474. PubMed ID: 29082518
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.